» Articles » PMID: 21321212

Loss of Cerebral Cavernous Malformation 3 (Ccm3) in Neuroglia Leads to CCM and Vascular Pathology

Overview
Specialty Science
Date 2011 Feb 16
PMID 21321212
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Communication between neural cells and the vasculature is integral to the proper development and later function of the central nervous system. A mechanistic understanding of the interactions between components of the neurovascular unit has implications for various disorders, including cerebral cavernous malformations (CCMs) in which focal vascular lesions form throughout the central nervous system. Loss of function mutations in three genes with proven endothelial cell autonomous roles, CCM1/krev1 interaction trapped gene 1, CCM2, and CCM3/programmed cell death 10, cause familial CCM. By using neural specific conditional mouse mutants, we show that Ccm3 has both neural cell autonomous and nonautonomous functions. Gfap- or Emx1-Cre-mediated Ccm3 neural deletion leads to increased proliferation, increased survival, and activation of astrocytes through cell autonomous mechanisms involving activated Akt signaling. In addition, loss of neural CCM3 results in a vascular phenotype characterized by diffusely dilated and simplified cerebral vasculature along with formation of multiple vascular lesions that closely resemble human cavernomas through cell nonautonomous mechanisms. RNA sequencing of the vascular lesions shows abundant expression of molecules involved in cytoskeletal remodeling, including protein kinase A and Rho-GTPase signaling. Our findings implicate neural cells in the pathogenesis of CCMs, showing the importance of this pathway in neural/vascular interactions within the neurovascular unit.

Citing Articles

Cerebral Cavernous Malformation: From Genetics to Pharmacotherapy.

Zhang Z, Deng J, Sun W, Wang Z Brain Behav. 2024; 15(1):e70223.

PMID: 39740786 PMC: 11688120. DOI: 10.1002/brb3.70223.


Pharmacological blocking of neutrophil extracellular traps attenuates immunothrombosis and neuroinflammation in cerebral cavernous malformation.

Onyeogaziri F, Smith R, Arce M, Huang H, Erzar I, Rorsman C Nat Cardiovasc Res. 2024; 3(12):1549-1567.

PMID: 39632986 PMC: 11634782. DOI: 10.1038/s44161-024-00577-y.


PDCD10 Is a Key Player in TMZ-Resistance and Tumor Cell Regrowth: Insights into Its Underlying Mechanism in Glioblastoma Cells.

Zhu Y, Kim S, Chen Z, Will R, Zhong R, Dammann P Cells. 2024; 13(17.

PMID: 39273014 PMC: 11394141. DOI: 10.3390/cells13171442.


mTORC1 Signaling in Brain Endothelial Progenitors Contributes to CCM Pathogenesis.

Min W, Qin L, Zhang H, Lopez-Giraldez F, Jiang N, Kim Y Circ Res. 2024; 135(4):e94-e113.

PMID: 38957991 PMC: 11293987. DOI: 10.1161/CIRCRESAHA.123.324015.


Transcriptomic signatures of individual cell types in cerebral cavernous malformation.

Li Y, Girard R, Srinath A, Vera Cruz D, Ciszewski C, Chen C Cell Commun Signal. 2024; 22(1):23.

PMID: 38195510 PMC: 10775676. DOI: 10.1186/s12964-023-01301-2.


References
1.
Seker A, Pricola K, Guclu B, Ozturk A, Louvi A, Gunel M . CCM2 expression parallels that of CCM1. Stroke. 2005; 37(2):518-23. DOI: 10.1161/01.STR.0000198835.49387.25. View

2.
Riant F, Bergametti F, Ayrignac X, Boulday G, Tournier-Lasserve E . Recent insights into cerebral cavernous malformations: the molecular genetics of CCM. FEBS J. 2010; 277(5):1070-5. DOI: 10.1111/j.1742-4658.2009.07535.x. View

3.
Thurston G, Wang Q, Baffert F, Rudge J, Papadopoulos N, Jean-Guillaume D . Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting, during a critical developmental period. Development. 2005; 132(14):3317-26. DOI: 10.1242/dev.01888. View

4.
Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban P . Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet. 1999; 23(1):99-103. DOI: 10.1038/12703. View

5.
Hilder T, Malone M, Bencharit S, Colicelli J, Haystead T, Johnson G . Proteomic identification of the cerebral cavernous malformation signaling complex. J Proteome Res. 2007; 6(11):4343-55. DOI: 10.1021/pr0704276. View